The Lancet regional health. Southeast Asia · 2026
Antimicrobial susceptibility of priority bacterial pathogens from laboratory samples in Timor-Leste: a retrospective analysis of database (2020-2025).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Oakley Tessa, da Costa Maia Carolina, Osorio do Rosario Celita, Soares Messias, Belo Joana Correia, da Conceição Virginia, Sarmento Névio, Toto Lucia, Amaral Elfiana, da Costa Campos Domingas, Allan Raikos, Champlin Karen, Soares da Silva Endang, Pereira Tilman Ari Jayanti, Guterres Helio, Alves Lucsendar, Draper Anthony Dk, Dickson Benjamin F R, Marr Ian, Yan Jennifer, Smith-Vaughan Heidi, Francis Joshua R
Аннотация
BACKGROUND: Antimicrobial resistance (AMR) is a major global health threat, with the highest burden in low-income and middle-income countries where diagnostic and surveillance capacity are often limited. Over the past decade, Timor-Leste has made substantial progress in strengthening microbial diagnostics and AMR surveillance capacity. We aimed to describe antimicrobial susceptibility patterns and temporal trends among priority bacterial pathogens in Timor-Leste between 2020 and 2025.
METHODS: We retrospectively analysed antimicrobial susceptibility patterns for WHO priority pathogens isolated from clinical samples processed at the Laboratory of Health, Instituto Nacional de Saúde Pública de Timor-Leste (INSP-TL), between June 2020 and January 2025. WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) priority pathogens were identified using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectrometry (MALDI-ToF) with automated antimicrobial susceptibility testing (AST) and interpreted using European Committee on AST (EUCAST) breakpoints. Duplicates within 12 months were excluded. Susceptibility proportions, temporal trends, and associations of AMR with sex, age, specimen type, and care were analysed.
FINDINGS: Of 4169 isolates, 2170 (52%) were from male and 1943 (47%) from female patients. Among Enterobacterales (1146/4169, 27%) ceftriaxone susceptibility of 65% (410/631) was observed in Escherichia coli and 25% (135/541) in Klebsiella pneumoniae. Carbapenem resistance was detected in 235 isolates, including 61 multidrug-resistant Acinetobacter baumannii complex. Meropenem susceptibility in E. coli decreased from 100% (33/33) in 2020 to 87% (155/178) in 2024 (p = 0.0002). Inpatient isolates of E. coli and K. pneumoniae showed lower ceftriaxone susceptibility than outpatient isolates. Staphylococcus aureus remained predominantly methicillin-susceptible (83%, 712/858).
INTERPRETATION: AMR burden in Timor-Leste is characterised by third-generation cephalosporin resistance, emerging carbapenem-resistant Enterobacterales, and multidrug-resistant A. baumannii. Sustained investment in infection prevention, antimicrobial stewardship, and laboratory systems is essential to mitigate further resistance emergence and guide treatment.
FUNDING: This work was supported by a Fleming Fund Country Grant (UK Aid).
METHODS: We retrospectively analysed antimicrobial susceptibility patterns for WHO priority pathogens isolated from clinical samples processed at the Laboratory of Health, Instituto Nacional de Saúde Pública de Timor-Leste (INSP-TL), between June 2020 and January 2025. WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) priority pathogens were identified using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight mass spectrometry (MALDI-ToF) with automated antimicrobial susceptibility testing (AST) and interpreted using European Committee on AST (EUCAST) breakpoints. Duplicates within 12 months were excluded. Susceptibility proportions, temporal trends, and associations of AMR with sex, age, specimen type, and care were analysed.
FINDINGS: Of 4169 isolates, 2170 (52%) were from male and 1943 (47%) from female patients. Among Enterobacterales (1146/4169, 27%) ceftriaxone susceptibility of 65% (410/631) was observed in Escherichia coli and 25% (135/541) in Klebsiella pneumoniae. Carbapenem resistance was detected in 235 isolates, including 61 multidrug-resistant Acinetobacter baumannii complex. Meropenem susceptibility in E. coli decreased from 100% (33/33) in 2020 to 87% (155/178) in 2024 (p = 0.0002). Inpatient isolates of E. coli and K. pneumoniae showed lower ceftriaxone susceptibility than outpatient isolates. Staphylococcus aureus remained predominantly methicillin-susceptible (83%, 712/858).
INTERPRETATION: AMR burden in Timor-Leste is characterised by third-generation cephalosporin resistance, emerging carbapenem-resistant Enterobacterales, and multidrug-resistant A. baumannii. Sustained investment in infection prevention, antimicrobial stewardship, and laboratory systems is essential to mitigate further resistance emergence and guide treatment.
FUNDING: This work was supported by a Fleming Fund Country Grant (UK Aid).